Broncho-Vaxom clinical trials
Also written OM-85.
How each study uses Broncho-Vaxom is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Broncho-Vaxom studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
14 studies that test it; most in 2021 (3)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 10
Medical University of Lublin (3) · Lallemand Pharma AG (2) · University of Arizona (1) · University of North Carolina, Chapel Hill (1) · The University of Queensland (1) · Chinese Academy of Medical Sciences (1) · Vifor Pharma (1) · Kecioren Education and Training Hospital (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Broncho-Vaxom is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 14
- Protecting Preterm Infants From Respiratory Tract Infections and Wheeze by Using Bacterial Lysates.RecruitingPhase 3Franciscus GasthuisNCT05063149Written as Broncho-VaxomHow we know
- Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract IllnessCompletedPhase 2University of ArizonaNCT02148796Written as Broncho-Vaxom (BV)How we know
- PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network StudyCompletedPhase 2University of North Carolina, Chapel HillNCT04129931Written as Broncho-VaxomHow we know
- Immunomodulation by OM-85 (Broncho-Vaxom) in Early ADTerminatedPhase 2OM Pharma SANCT05222516Written as Broncho-VaxomHow we know
- Effect of Bacterial Lysate on Nasal Carriage of Staphylococcus AureusCompletedPhase 3Medical University of LublinNCT04637425Written as IsmigenHow we know
- The Influence of Nonspecific Immunostimulation on Changes in the Concentration of iNKT CellsCompletedPhase 3Medical University of LublinNCT04802616Written as IsmigenHow we know
- Reducing Acute Severe Respiratory Events in Health Care Workers During the Covid-19 Pandemic With OM85CompletedPhase 3The University of QueenslandNCT04496245Written as Broncho-Vaxom®How we know
- Efficacy and Safety of Broncho-Vaxom in the First Episode of Pediatric Idiopathic Nephrotic SyndromeStatus unknownNot applicableFang DengNCT05044169Written as Broncho-VaxomHow we know
- Efficacy Of Bacterial Lysate In Children With Allergic RhinitisCompletedPhase 3Medical University of LublinNCT04270552Written as IsmigenHow we know
- Prevention of OM-85 on Bronchiectasis ExacerbationCompletedPhase 4Chinese Academy of Medical SciencesNCT01968421Written as OM-85 BVHow we know
- Broncho-Vaxom (OM 85 BV) in Children Suffering From Atopic DermatitisCompletedPhase 3Vifor PharmaNCT03047954Written as Broncho-VaxomHow we know
- Efficacy Of Bacterial Lysate In Asthmatic ChildrenCompletedPhase 3Lallemand Pharma AGNCT02541331Written as ISMIGENHow we know
- Advanced Immunological Approach in COPD ExacerbationCompletedPhase 4Lallemand Pharma AGNCT02417649Written as IsmigenHow we know
- Effect of OM-85 BV on Wheezing Related Morbidity in Children With Recurrent WheezingCompletedPhase 4Kecioren Education and Training HospitalNCT00733226Written as OM-85 BV (Broncho-Vaxom)How we know
Codes
What other systems call Broncho-Vaxom · ClinicalTrials.gg INT002913
- MeSH (NLM) C030259Broncho-VaxomOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C030259 | Broncho-Vaxom | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.